David Erwin Kleiner
National Institutes of Health · 1,005 works · 89,982 citations · h-index 134
Top works
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B
- Quantitative Zymography: Detection of Picogram Quantities of Gelatinases
- Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
- Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
- Ribavirin as Therapy for Chronic Hepatitis C
- Structural biochemistry and activation of matrix metalloproteases
- Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1